29 Jan 2016 17:27
RECKITT BENCKISER GROUP PLC
TRANSACTION IN OWN SECURITIES
Reckitt Benckiser Group plc ("RB") announces today that it has purchased the following number of its ordinary shares of 10p each (the "Ordinary Shares") on the London Stock Exchange from Morgan Stanley & Co. International PLC ("Morgan Stanley"). Such purchase was effected pursuant to irrevocable instructions issued by RB on 30 December 2015, as announced on 30 December 2015:
Ordinary Shares
Date of purchase: | 29 January 2016 |
Number of Ordinary Shares purchased: | 39,724 |
Price per share: | £61.9493 |
RB intends to hold the purchased shares in treasury.
Following the above transaction, RB holds 29,363,346 Ordinary Shares in treasury and has 707,171,833 Ordinary Shares in issue (excluding treasury shares).
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
Contact:
Christine Logan
Company Secretary
Reckitt Benckiser Group plc
01753 217800
About RB:
RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately c. 37,000 people worldwide.
Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.
RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one the world's largest killer of under 5s, diarrhoea.
For more information visit www.rb.com
*RB is the trading name of Reckitt Benckiser group of companies